Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution

MLA

Vaia Florou, et al. “Angiosarcoma Patients Treated with Immune Checkpoint Inhibitors: A Case Series of Seven Patients from a Single Institution.” Journal for ImmunoTherapy of Cancer, vol. 7, no. 1, Aug. 2019, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s40425-019-0689-7.

APA

Vaia Florou, Andrew E. Rosenberg, Eric Wieder, Krishna V. Komanduri, Despina Kolonias, Mohamed Uduman, John C. Castle, Jennifer S. Buell, Jonathan C. Trent, & Breelyn A. Wilky. (2019). Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution. Journal for ImmunoTherapy of Cancer, 7(1), 1–8. https://doi.org/10.1186/s40425-019-0689-7

Chicago

Vaia Florou, Andrew E. Rosenberg, Eric Wieder, Krishna V. Komanduri, Despina Kolonias, Mohamed Uduman, John C. Castle, Jennifer S. Buell, Jonathan C. Trent, and Breelyn A. Wilky. 2019. “Angiosarcoma Patients Treated with Immune Checkpoint Inhibitors: A Case Series of Seven Patients from a Single Institution.” Journal for ImmunoTherapy of Cancer 7 (1): 1–8. doi:10.1186/s40425-019-0689-7.